Full-Time

Data Engineer

Posted on 7/8/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Mid, Senior

Hyderabad, Telangana, India

In Person

Category
Data Engineering
Data & Analytics
Required Skills
Agile
Python
MySQL
Apache Spark
SQL
Postgres
AWS
JIRA
Scala
MongoDB
Confluence
Development Operations (DevOps)
Databricks
Requirements
  • Hands-on experience in data engineering technologies such as Databricks, PySpark, SparkSQL Apache Spark, AWS, Python, SQL, and Scaled Agile methodologies.
  • Proficiency in workflow orchestration, performance tuning on big data processing.
  • Strong understanding of AWS services
  • Ability to quickly learn, adapt and apply new technologies
  • Strong problem-solving and analytical skills
  • Excellent communication and teamwork skills
  • Experience with Scaled Agile Framework (SAFe), Agile delivery practices, and DevOps practices.
Responsibilities
  • Design, develop, and maintain complex ETL/ELT data pipelines in Databricks using PySpark, Scala, and SQL to process large-scale datasets
  • Understand the biotech/pharma or related domains & build highly efficient data pipelines to migrate and deploy complex data across systems
  • Design and Implement solutions to enable unified data access, governance, and interoperability across hybrid cloud environments
  • Ingest and transform structured and unstructured data from databases (PostgreSQL, MySQL, SQL Server, MongoDB etc.), APIs, logs, event streams, images, pdf, and third-party platforms
  • Ensuring data integrity, accuracy, and consistency through rigorous quality checks and monitoring
  • Expert in data quality, data validation and verification frameworks
  • Innovate, explore and implement new tools and technologies to enhance efficient data processing
  • Proactively identify and implement opportunities to automate tasks and develop reusable frameworks
  • Work in an Agile and Scaled Agile (SAFe) environment, collaborating with cross-functional teams, product owners, and Scrum Masters to deliver incremental value
  • Use JIRA, Confluence, and Agile DevOps tools to manage sprints, backlogs, and user stories.
  • Support continuous improvement, test automation, and DevOps practices in the data engineering lifecycle
  • Collaborate and communicate effectively with the product teams, with cross-functional teams to understand business requirements and translate them into technical solutions.
Desired Qualifications
  • Data Engineering experience in Biotechnology or pharma industry
  • Experience in writing APIs to make the data available to the consumers
  • Experienced with SQL/NOSQL database, vector database for large language models
  • Experienced with data modeling and performance tuning for both OLAP and OLTP databases
  • Experienced with software engineering best-practices, including but not limited to version control (Git, Subversion, etc.), CI/CD (Jenkins, Maven etc.), automated unit testing, and Dev Ops
  • AWS Certified Data Engineer preferred
  • Databricks Certificate preferred
  • Scaled Agile SAFe certification preferred

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective treatments for serious health conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

INACTIVE